Healthcare provider profile · identity verified

Virginia Halachanova, M.D.

Internal Medicine · PAULDING, OH · NPI 1417906272

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	634	179
Amlodipine Besylate	Amlodipine Besylate	438	120
Levothyroxine Sodium	Levothyroxine Sodium	329	86
Losartan Potassium	Losartan Potassium	293	76
Lisinopril	Lisinopril	274	76
Metoprolol Succinate	Metoprolol Succinate	248	75
Pantoprazole Sodium	Pantoprazole Sodium	235	59
Sertraline Hcl	Sertraline Hcl	232	57
Fluoxetine Hcl	Fluoxetine Hcl	222	55
Famotidine	Famotidine	211	66
Montelukast Sodium	Montelukast Sodium	198	50
Omeprazole	Omeprazole	192	53
Potassium Chloride	Potassium Chloride	192	50
Pravastatin Sodium	Pravastatin Sodium	185	50
Buspirone Hcl	Buspirone Hcl	180	57
Metformin Hcl	Metformin Hcl	174	54
Fluticasone Propionate	Fluticasone Propionate	165	68
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	149	44
Hydrochlorothiazide	Hydrochlorothiazide	137	38
Alendronate Sodium	Alendronate Sodium	127	30
Eliquis	Apixaban	127	22
Metformin Hcl Er	Metformin Hcl	120	35
Jardiance	Empagliflozin	117	17
Ozempic	Semaglutide	117	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	102	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	98	35
Furosemide	Furosemide	97	23
Metoprolol Tartrate	Metoprolol Tartrate	97	26
Duloxetine Hcl	Duloxetine Hcl	96	17
Celecoxib	Celecoxib	94	32
Farxiga	Dapagliflozin Propanediol	93	21
Tamsulosin Hcl	Tamsulosin Hcl	93	25
Tramadol Hcl	Tramadol Hcl	93	18
Glimepiride	Glimepiride	90	23
Synthroid	Levothyroxine Sodium	84	22
Gabapentin	Gabapentin	83	27
Carvedilol	Carvedilol	82	19
Rosuvastatin Calcium	Rosuvastatin Calcium	82	22
Albuterol Sulfate Hfa	Albuterol Sulfate	80	35
Simvastatin	Simvastatin	74	20
Alprazolam	Alprazolam	70	21
Ipratropium Bromide	Ipratropium Bromide	69	45
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	67	21
Ezetimibe	Ezetimibe	65	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	12
Trazodone Hcl	Trazodone Hcl	61	16
Allopurinol	Allopurinol	59	17
Donepezil Hcl	Donepezil Hcl	59	16
Nystatin	Nystatin	59	30
Methylprednisolone	Methylprednisolone	58	50
Pioglitazone Hcl	Pioglitazone Hcl	57	14
Clopidogrel	Clopidogrel Bisulfate	56	12
Terazosin Hcl	Terazosin Hcl	56	17
Mounjaro	Tirzepatide	54	12
Meloxicam	Meloxicam	53	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	52	15
Spironolactone	Spironolactone	49	14
Atenolol	Atenolol	46	14
Cephalexin	Cephalexin	44	38
Azithromycin	Azithromycin	43	38
Invokana	Canagliflozin	41	suppressed
Januvia	Sitagliptin Phosphate	41	suppressed
Paroxetine Hcl	Paroxetine Hcl	41	suppressed
Meclizine Hcl	Meclizine Hcl	38	15
Nifedipine Er	Nifedipine	36	11
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Prednisone	Prednisone	34	20
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	23
Diazepam	Diazepam	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	23
Fenofibrate	Fenofibrate	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Memantine Hcl Er	Memantine Hcl	25	suppressed
Gemfibrozil	Gemfibrozil	24	suppressed
Ketoconazole	Ketoconazole	24	12
Lovastatin	Lovastatin	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	20
Verapamil Er	Verapamil Hcl	24	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	17
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Primidone	Primidone	20	suppressed
Ramipril	Ramipril	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Finasteride	Finasteride	17	suppressed
Galantamine Hbr	Galantamine Hbr	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	13	suppressed
Torsemide	Torsemide	13	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error